Cutaneous β-human papillomavirus E6 proteins bind Mastermind-like coactivators and repress Notch signaling

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 23, 2012, Pages

  Tan, Min Jie Alvin ^a   White, Elizabeth A ^a   Sowa, Mathew E ^a   Harper, J Wade ^a   Aster, Jon C ^b   Howley, Peter M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Notch1; Proteomics; Skin cancer

Indexed keywords

NOTCH RECEPTOR; PROTEIN E6; PROTEIN MASTERMIND LIKE 1; PROTEIN MASTERMIND LIKE 3; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BOVINE PAPILLOMAVIRUS TYPE 1; CELL INTERACTION; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SKIN PAPILLOMA; TRANSCRIPTION INITIATION; WART VIRUS;

ANIMALS; BETAPAPILLOMAVIRUS; BLOTTING, WESTERN; CELL LINE; DNA-BINDING PROTEINS; HUMANS; LUCIFERASES; MICE; ONCOGENE PROTEINS, VIRAL; PLASMIDS; PROTEOMICS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFECTION;

BOVINE PAPILLOMAVIRUS TYPE 1; HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 84861875855     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1205991109     Document Type: Article

References (51)

1. Howley PM, Lowy DR (2007) Papillomaviruses. Fields Virology, eds Knipe D, Howley P (Lippincott Williams and Wilkins, Philadelphia), 5th Ed, pp 2299-2354.
2. Jablonska S, Orth G (1985) Epidermodysplasia verruciformis. Clin Dermatol 3:83-96.
3. Akgül B, Cooke JC, Storey A (2006) HPV-associated skin disease. J Pathol 208:165-175. (Pubitemid 43126110)
4. Antonsson A, et al. (2003) Prevalence and type spectrum of human papillomaviruses in healthy skin samples collected in three continents. J Gen Virol 84:1881-1886. (Pubitemid 36805924)
5. Huibregtse JM, Scheffner M, Howley PM (1991) A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J 10:4129-4135. (Pubitemid 21905444)
6. Huibregtse JM, Scheffner M, Howley PM (1993) Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol Cell Biol 13:775-784. (Pubitemid 23040242)
7. Gardiol D, et al. (1999) Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene 18: 5487-5496. (Pubitemid 29481495)
8. Nakagawa S, Huibregtse JM (2000) Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol Cell Biol 20:8244-8253.
9. Cooper B, et al. (2003) Requirement of E6AP and the features of human papillomavirus E6 necessary to support degradation of p53. Virology 306:87-99. (Pubitemid 36293399)
10. Jackson S, Harwood C, Thomas M, Banks L, Storey A (2000) Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev 14:3065-3073.
11. Caldeira S, et al. (2004) p53 mutations are common in human papillomavirus type 38-positive non-melanoma skin cancers. Cancer Lett 209:119-124. (Pubitemid 38625751)
12. Wu L, et al. (2000) MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors. Nat Genet 26:484-489.
13. Artavanis-Tsakonas S, Rand MD, Lake RJ (1999) Notch signaling: Cell fate control and signal integration in development. Science 284:770-776. (Pubitemid 29291335)
14. Nam Y, Aster JC, Blacklow SC (2002) Notch signaling as a therapeutic target. Curr Opin Chem Biol 6:501-509. (Pubitemid 34804774)
15. Lowell S, Jones P, Le Roux I, Dunne J, Watt FM (2000) Stimulation of human epidermal differentiation by delta-notch signalling at the boundaries of stem-cell clusters. Curr Biol 10:491-500. (Pubitemid 30308306)
16. Rangarajan A, et al. (2001) Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J 20:3427-3436. (Pubitemid 32634350)
17. Stransky N, et al. (2011) The mutational landscape of head and neck squamous cell carcinoma. Science 333:1157-1160.
18. Agrawal N, et al. (2011) Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333:1154-1157.
19. Wang NJ, et al. (2011) Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc Natl Acad Sci USA 108:17761-17766.
20. Sowa ME, Bennett EJ, Gygi SP, Harper JW (2009) Defining the human deubiquitinating enzyme interaction landscape. Cell 138:389-403.
21. White EA, et al. (2012) Systematic identification of interactions between host cell proteins and E7 oncoproteins from diverse human papillomaviruses. Proc Natl Acad Sci USA 109:E260-E267.
22. Chen JJ, Hong Y, Rustamzadeh E, Baleja JD, Androphy EJ (1998) Identification of an alpha helical motif sufficient for association with papillomavirus E6. J Biol Chem 273: 13537-13544. (Pubitemid 28268395)
23. Vande Pol SB, Brown MC, Turner CE (1998) Association of bovine papillomavirus type 1 E6 oncoprotein with the focal adhesion protein paxillin through a conserved protein interaction motif. Oncogene 16:43-52. (Pubitemid 28043506)
24. Tong X, Howley PM (1997) The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. Proc Natl Acad Sci USA 94:4412-4417. (Pubitemid 27194255)
25. Huibregtse JM, Scheffner M, Howley PM (1993) Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol Cell Biol 13:4918-4927. (Pubitemid 23220397)
26. Ronco LV, Karpova AY, Vidal M, Howley PM (1998) Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev 12:2061-2072. (Pubitemid 28323879)
27. Luo B, Aster JC, Hasserjian RP, Kuo F, Sklar J (1997) Isolation and functional analysis of a cDNA for human Jagged2, a gene encoding a ligand for the Notch1 receptor. Mol Cell Biol 17:6057-6067. (Pubitemid 27411114)
28. Weng AP, et al. (2003) Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling. Mol Cell Biol 23:655-664. (Pubitemid 36050558)
29. Brimer N, Lyons C, Wallberg AE, Vande Pol SB (2012) Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling. Oncogene, 31, in press.
30. Nam Y, Sliz P, Song L, Aster JC, Blacklow SC (2006) Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes. Cell 124: 973-983. (Pubitemid 43344237)
31. Nam Y, Weng AP, Aster JC, Blacklow SC (2003) Structural requirements for assembly of the CSL.intracellular Notch1.Mastermind-like 1 transcriptional activation complex. J Biol Chem 278:21232-21239. (Pubitemid 36806438)
32. Proweller A, et al. (2006) Impaired notch signaling promotes de novo squamous cell carcinoma formation. Cancer Res 66:7438-7444. (Pubitemid 44289196)
33. McElhinny AS, Li JL, Wu L (2008) Mastermind-like transcriptional co-activators: emerging roles in regulating cross talk among multiple signaling pathways. Oncogene 27:5138-5147.
34. Radtke F, Raj K (2003) The role of Notch in tumorigenesis: Oncogene or tumour suppressor? Nat Rev Cancer 3:756-767. (Pubitemid 37328814)
35. Weng AP, et al. (2004) Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306:269-271. (Pubitemid 39336870)
36. Nicolas M, et al. (2003) Notch1 functions as a tumor suppressor in mouse skin. Nat Genet 33:416-421. (Pubitemid 36278861)
37. Lefort K, et al. (2007) Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKalpha kinases. Genes Dev 21:562-577. (Pubitemid 46409471)
38. Yugawa T, et al. (2007) Regulation of Notch1 gene expression by p53 in epithelial cells. Mol Cell Biol 27:3732-3742. (Pubitemid 46726180)
39. Liang Y, Chang J, Lynch SJ, Lukac DM, Ganem D (2002) The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. Genes Dev 16:1977-1989. (Pubitemid 34832925)
40. Grossman SR, Johannsen E, Tong X, Yalamanchili R, Kieff E (1994) The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein. Proc Natl Acad Sci USA 91:7568-7572.
41. Zimber-Strobl U, et al. (1994) Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless. EMBO J 13: 4973-4982.
42. Jones DL, Alani RM, Münger K (1997) The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev 11:2101-2111. (Pubitemid 27369104)
43. Funk JO, et al. (1997) Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev 11: 2090-2100. (Pubitemid 27369103)
44. Dickson MA, et al. (2000) Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 20:1436-1447. (Pubitemid 30069263)
45. Heilman CA, Engel L, Lowy DR, Howley PM (1982) Virus-specific transcription in bovine papillomavirus-transformed mouse cells. Virology 119(1):22-34. (Pubitemid 12100676)
46. Pfister H, Nürnberger F, Gissmann L, zur Hausen H (1981) Characterization of a human papillomavirus from epidermodysplasia verruciformis lesions of a patient from Uppervolta. Int J Cancer 27:645-650. (Pubitemid 11101750)
47. Kremsdorf D, et al. (1984)Molecular cloning and characterization of the genomes of nine newly recognized human papillomavirus types associated with epidermodysplasia verruciformis. J Virol 52:1013-1018. (Pubitemid 15216338)
48. ScheurlenW, Gissmann L, Gross G, zur Hausen H (1986) Molecular cloning of two new HPV types (HPV 37 and HPV 38) from a keratoacanthoma and a malignant melanoma. Int J Cancer 37:505-510. (Pubitemid 16108588)
49. Jarriault S, et al. (1995) Signalling downstream of activated mammalian Notch. Nature 377:355-358.
50. Aster JC, et al. (2000) Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by notch1. Mol Cell Biol 20:7505-7515.
51. Hasserjian RP, Aster JC, Davi F, Weinberg DS, Sklar J (1996) Modulated expression of notch1 during thymocyte development. Blood 88:970-976. (Pubitemid 26333321)